News Headlines

Display #
Innovation and robotics will speed up tumor analysis
Vitamin C May Encourage Blood Cancer Stem Cells to Die
Deficiencies in early brain activity linked to delinquent behavior in teens
FDA approves rare blood cancer drug
FDA provides new tools for the development and proper evaluation of tests for detecting Zika virus infection
FDA expands use of ovarian cancer drug
Philippines reports second outbreak of bird flu
Lyfebulb-Novo Nordisk Innovation Award 2017
Bristol-Myers Kidney Cancer Drug Flunks Study
FDA Accepts Adcetris Supplemental BLA for CTLC
Repatha® (evolocumab) phase 3 cognitive function study results published in the New England Journal of Medicine
'Accelerated approval' drugs: How well are they studied?
Trump to make August cost-sharing payments to health insurers
Repatha Phase 3 Cognitive Function Study Results Published In The New England Journal Of Medicine
Gene variant activity is surprisingly variable between tissues
Johnson & Johnson CEO Backpedals and Quits Right Before Trump Disbands Council
Arcus Biosciences, Wuxi Biologics Hammer Out R&D Cancer Pact Worth $816 Million+
Mylan, U.S. finalize EpiPen settlement
House Democrats launch MS drug pricing probe
Novo Nordisk’s semaglutide beats out Trulicity
FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia
Light-to-moderate alcohol consumption may have protective health effects
Discovery Worldwide Names Stephanie Franke as VP, Creative Director
South Carolina sues OxyContin maker Purdue
Lack of sleep tied to higher risk of diabetes in kids
Bristol-Myers Squibb announces topline results from CheckMate -214
A metabolic treatment for pancreatic cancer?
Centene to sell Obamacare plans in Nevada during 2018
Flimsy evidence behind many FDA approvals
End of U.S. payments to health insurers would cause premiums to rise: CBO